It’s next to impossible not to have heard about the new-diabetes-drug-turned-weight-loss-darling, Ozempic.
While I have prescribed this drug—and have witnessed amazing results in my patients—let’s shift our focus just a bit.
Because now, researchers are looking at the potential of such drugs to tackle some of the most difficult-to-treat brain disorders, like Alzheimer’s.
Here’s everything you need to know…
Inflammation and high blood sugar
Diabetes medications are often used for off-label purposes.
In fact, metformin has been an anti-aging darling for over a decade. Others are used to treat polycystic ovary syndrome (PCOS)… the list goes on.
Now, such drugs are also being studied to see if they can tackle neurodegenerative disorders.
Because of the drugs’ ability to address different aspects of the metabolic system—like inflammation and a protein called amyloid—which are ALSO implicated in these brain diseases.
So, the mainstream’s hope is that these drugs can tamp down systemic inflammation (by helping to control blood sugar), while slowing progression of debilitating diseases like Alzheimer’s and Parkinson’s.
All I can say is: Hallelujah! Could they finally be understanding the effects of chronic inflammation and excess sugar on the body?
New hope for the aging population
This is the same concept I’ve been discussing for DECADES. And as a regular reader, you already know how these two things can affect the body.
In fact, high blood sugar and inflammation can lead to any number of chronic diseases, such as diabetes, heart disease, obesity, stroke, cancer, even early death!
And while we’re still early in the game, I think looking at what we already have (Ozempic) and seeing if we can use it in a different way is a GREAT idea. It’s a lot faster and cheaper than looking for new drugs or therapies—those would take decades.
Plus, we have so many neurological disorders that we’re currently quite BAD at treating… that it’s really high time for us to look anywhere and everywhere to help the aging population.
And ANY success of these drugs being used for neurodegenerative diseases could lead to a BIG payoff.
I mean, dementia affects more than 55 million people globally—and the market for Alzheimer’s drugs is expected to grow to $9.4 billion by 2028 ($6.6 billion for Parkinson’s). So, with this much money at stake, you can bet Big Pharma is chomping at the bit.
It’ll be interesting to see where this research lands, so I’ll be sure to keep you updated.
In the meantime, continuing to lead a healthy lifestyle is your best defense at keeping high blood sugar, inflammation, and a host of diseases at bay.
For more details about how to protect and restore your brain over the years, I encourage you to check out my online learning tool, my Alzheimer’s Prevention and Treatment Plan. Click here to learn more!
“After Weight Loss, Alzheimer’s May Be Next Frontier for Drugs Like Ozempic.” Medscape, 05/09/2023. (medscape.com/viewarticle/991675)